Thoracic Neoplasms Clinical Trials

9 recruiting

Thoracic Neoplasms Trials at a Glance

10 actively recruiting trials for thoracic neoplasms are listed on ClinicalTrialsFinder across 6 cities in 5 countries. The largest study group is Phase 2 with 4 trials, with the heaviest enrollment activity in Washington D.C., Charlotte, and Columbus. Lead sponsors running thoracic neoplasms studies include China Medical University Hospital, Chinese University of Hong Kong, and Affiliated Hospital of Nantong University.

Browse thoracic neoplasms trials by phase

Treatments under study

About Thoracic Neoplasms Clinical Trials

Looking for clinical trials for Thoracic Neoplasms? There are currently 9 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Thoracic Neoplasms trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Thoracic Neoplasms clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 110 of 10 trials

Recruiting

Local Radiofrequency Ablation Plus External Beam Radiation for the Treatment of Painful Thoracic and Lumbar Spine Tumors

Thoracic NeoplasmsLumbar Neoplasm
UNC Lineberger Comprehensive Cancer Center70 enrolled1 locationNCT07479199
Recruiting
Phase 1Phase 2

A Study of YL201 in Combination With Other Anti-Cancer Therapies in Patients With Advanced Solid Tumors

Thoracic Neoplasms, Lung Diseases, Small Cell Lung Carcinoma
MediLink Therapeutics (Suzhou) Co., Ltd.118 enrolled4 locationsNCT07407933
Recruiting
Not Applicable

Post-operative Medium Chain Triglyceride Diet May Reduce Hospital Stay Following Lung Resection

Thoracic Neoplasms
Chinese University of Hong Kong210 enrolled1 locationNCT07159659
Recruiting
Phase 4

Erector Spinae Block for Thoracic Surgery

Thoracic CancerPulmonary CancerThoracic Neoplasms+2 more
George Washington University70 enrolled1 locationNCT05521789
Recruiting
Phase 2

Clinical Study of Thiopegfilgrastim for Preventing Bone Marrow Suppression in Thoracic Tumor Chemoradiotherapy

Thoracic NeoplasmsChemoradiotherapyMyelosuppression
Affiliated Hospital of Nantong University30 enrolled1 locationNCT07205536
Recruiting
Phase 2

Post-line Treatment With Teniposide for c-Myc-driven Extensive-stage Small Cell Lung Cancer

Lung NeoplasmsThoracic NeoplasmsLung Diseases+1 more
Shanghai Pulmonary Hospital, Shanghai, China15 enrolled1 locationNCT06758700
Recruiting

Real World Registry for Use of the Ion Endoluminal System

Lung CancerLung NeoplasmsNeoplasms+6 more
Intuitive Surgical3,000 enrolled16 locationsNCT06004440
Recruiting
Not Applicable

Early Intervention Strategies for Lung Cancer

Lung NeoplasmsNeoplasmsNeoplasms by Site+4 more
The First Affiliated Hospital of Guangzhou Medical University16,000 enrolled1 locationNCT06988943
Recruiting
Not Applicable

The Effects of a Family-Centered Tai Chi Exercise on Lung Function and Mental Health of Patients After Thoracoscopic Surgery

Thoracic Neoplasms
China Medical University Hospital200 enrolled1 locationNCT06104774
Recruiting
Phase 2

A Phase Ⅱ Clinical Study of Adebrelimab Combined With Chemotherapy and Concurrent Radiotherapy for Extensive-Stage Oligometastatic SCLC

Lung NeoplasmsNeoplasmsNeoplasms by Site+7 more
Nanfang Hospital, Southern Medical University62 enrolled1 locationNCT06177925